Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A Strategic Asset Allocation Index
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A strategic asset allocation index. Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A (300760) has a Strategic Asset Allocation Index of 20.4% as of June 2023. Strategic assets (PP&E of CN¥6.83 Billion plus long-term investments of CN¥-) total CN¥6.83 Billion, measured against net assets of CN¥33.50 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Shenzhen Mindray Bio-Medical Electronics tangible book value ratio to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A (2015–2022)
Strategic asset allocation index of Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A from 2015 to 2022. This chart shows how Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A's Strategic Asset Allocation Index has evolved across 8 annual periods from 2015 to 2022. As of June 2023, the index stands at 20.4%, representing strategic assets of CN¥6.83 Billion against net assets of CN¥33.50 Billion CNY.
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A Strategic Asset Allocation Index by Year (2015–2022)
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A strategic asset allocation index by year from 2015 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A from 2015 to 2022, covering 8 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of Shenzhen Mindray Bio-Medical Electronics.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 19.7% | CN¥6.29 Billion | CN¥6.29 Billion | CN¥- | CN¥32.00 Billion | ▲ +0.6 pp |
| 2021 | 19.0% | CN¥5.13 Billion | CN¥5.13 Billion | CN¥- | CN¥26.97 Billion | ▲ +1.3 pp |
| 2020 | 17.7% | CN¥4.13 Billion | CN¥4.13 Billion | CN¥- | CN¥23.29 Billion | ▼ -1.9 pp |
| 2019 | 19.7% | CN¥3.66 Billion | CN¥3.66 Billion | CN¥- | CN¥18.62 Billion | ▼ -2.8 pp |
| 2018 | 22.5% | CN¥3.41 Billion | CN¥3.41 Billion | CN¥- | CN¥15.18 Billion | ▼ -24.2 pp |
| 2017 | 46.7% | CN¥3.11 Billion | CN¥3.11 Billion | CN¥- | CN¥6.65 Billion | ▼ -18.0 pp |
| 2016 | 64.7% | CN¥2.98 Billion | CN¥2.98 Billion | CN¥- | CN¥4.60 Billion | ▲ +20.6 pp |
| 2015 | 44.0% | CN¥2.88 Billion | CN¥2.88 Billion | CN¥- | CN¥6.54 Billion | — |